✦ LIBER ✦

A particular hepatitis C virus protease NS3 gene pattern in a patient not responding to interferon-ribavirin therapy

✍ Scribed by S. Vallet; J. B. Nousbaum; S. Gouriou; M. C. Legrand-Quillien; A. Goudeau; B. Picard

Book ID: 106271303
Publisher: Springer
Year: 2004
Tongue: English
Weight: 385 KB
Volume: 24
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-004-1269-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evolution of hepatitis C virus NS5A regi

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy

✍ H. J. Yuan; M. Jain; K. K. Snow; M. Gale Jr; W. M. Lee; the HALT-C Trial Group 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Identification of a hepatitis C virus mu

Identification of a hepatitis C virus mutant lacking the hypervariable region 1 in a chronically infected patient non-responding to PEG-interferon-α/ribavirin therapy

✍ D. Kmieciak; P. Migdalski; J. Juszczyk; P. P. Jagodziński; W. H. Trzeciak 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 111 KB

Interferon and ribavirin therapy does no

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase

✍ C. L. Ward; A. Dev; S. Rigby; W. T. Symonds; K. Patel; A. Zekry; J.-M. Pawlotsky 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Sequential versus concomitant administra

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial

✍ Raffaello Sostegni; Valeria Ghisetti; Fabrizia Pittaluga; Giovanna Marchiaro; Gi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

We conducted a three-arm, randomized trial in 96 patients with chronic hepatitis C who did not respond to interferon alfa to compare treatments. Group 1 (33 patients) received ribavirin alone (1,000 mg/daily for 6 months) followed by interferon alfa n-3 alone (3 MU thrice weekly for 6 months); group

Adverse skin reactions due to pegylated

Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus

✍ Yuki HASHIMOTO; Hiromi KANTO; Masatoshi ITOH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 1023 KB

A randomized trial of pegylated-interfer

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB